News

Abstract submission to the EAS Congress 2016 is open!

12.11.20151897

Be part of EAS 2016 - an outstanding scientific programme covering recent developments in the field of atherosclerosis-related disease and clinical therapies.

Dyspnea, bleeding most common causes of ticagrelor discontinuation

12.11.20152138

The most frequent causes of ticagrelor discontinuation in the PEGASUS?TIMI 54 study were dyspnea and bleeding, and many of those events were minor, according to results of a substudy presented at the American Heart Association Scientific Sessions.

Russian Journal of Cardiology is now available in English

11.11.20152389

In 2016 articles both original and already published and translated into English can be submitted to the Russian Journal of Cardiology.

Russian Journal of Cardiology is going to issue in 2016

11.11.20152194

Russian Journal of Cardiology is going to issue in 2016 ESC guidelines and textbook.

FDA: No Raised Mortality, Cancer Risk With Long-Term Clopidogrel

11.11.20151862

The announcement was based on a review of the Dual Antiplatelet Therapy (DAPT) trial, as well as of other large clinical trials that also examined adverse events from clopidogrel use.

Macrolide exposure influences risk for cardiac death, arrhythmia

10.11.20151817

The use of macrolide antibiotics may be associated with a minor increase in the risk for sudden cardiac death or ventricular tachyarrhythmias, according to the results of a recently published meta-analysis.

2015 ESC Guidelines for Pericardial Disease

06.11.20152818

2015 ESC Guidelines for Pericardial Disease.